This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from multiple institutions conducted a meta-analysis to assess the safety and efficacy of oral immunotherapy for peanut allergy. Investigators searched MEDLINE, Embase, the Cochrane Controlled Register of Trials, and databases at the US Food and Drug Administration and European Medicines Agency from inception to 2018 to identify published and unpublished randomized controlled trials (RCTs) comparing oral immunotherapy with placebo or allergen avoidance for the treatment of peanut allergy.
The investigators pooled data among included studies for several outcomes, including (a) peanut-induced anaphylaxis, defined as involvement of ≥2 organ systems after possible allergen exposure; (b) epinephrine use; (c) serious …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Related Articles
Cited By...
- No citing articles found.